Has David Albala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $639,845 in general payments to David Albala, MD across 368 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Albala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Albala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Albala, MD

Urology · Syracuse, NYNPI 1386734531

Payments from drug & device makers

$639,845in general payments, 2019–2025

Across 368 payments — averaging $1738.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Applied Medical Corporation$501K
Progenics Pharmaceuticals, Inc.$49K
Boston Scientific$26K
Janssen Scientific Affairs, LLC$14K
Blue Earth Diagnostics$7K
Siemens Medical Solutions USA, Inc.$6K
plus $37K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Applied Medical Corporation	7	$501,114
Progenics Pharmaceuticals, Inc.	35	$48,621
Boston Scientific	39	$26,362
Janssen Scientific Affairs, LLC	24	$13,777
Blue Earth Diagnostics	15	$6,960
Siemens Medical Solutions USA, Inc.	11	$5,942
Applied Medical Resources Corporation	14	$5,746
Intuitive Surgical	18	$4,976
Foundation Medicine, Inc.	5	$4,033
Janssen Global Services, LLC	2	$3,283
Myovant Sciences Inc.	4	$3,195
Amgen	5	$2,054
Urogen Pharma, Inc.	13	$1,804
EDAP Technomed Inc	16	$1,772
Procept Biorobotics Corporation	15	$1,584
Teleflex LLC	7	$1,333
Provepharm Inc.	2	$1,142
C. R. Bard, Inc. & Subsidiaries	4	$988
Myriad Genetic Laboratories, Inc.	13	$969
Johnson & Johnson(2 entities)	17	$631
Novo Nordisk	1	$595
Astellas Pharma US Inc	11	$393
Novartis	4	$260
Pfizer	6	$237
Dendreon Pharmaceuticals LLC	5	$183
Sanofi	1	$144
Antares Pharma, Inc.	6	$141
Palette Life Sciences, Inc.	3	$131
Tolmar Pharmaceuticals, Inc.	7	$127
Accord Healthcare, Inc.	2	$124
Bayer	2	$112
Merck	5	$103
AbbVie	5	$96
Endo Pharmaceuticals Inc.	4	$83
Sumitomo Pharma America, Inc.	4	$82
Bioprotect Medical, Inc.	3	$73
Olympus America Inc.	3	$72
Coloplast	3	$66
Neotract Inc.	1	$60
Immunitybio, Inc.	3	$55
AstraZeneca	1	$50
Vertex	2	$42
Urovant Sciences Inc	2	$38
Endo USA, Inc.	2	$36
Ferring Pharmaceuticals Inc.	2	$35
Halozyme Inc	1	$33
Alnylam Pharmaceuticals Inc.	2	$32
Laborie Medical Technologies Corp.	1	$30
Travere Therapeutics, Inc.	2	$26
Sun Pharmaceutical Industries Inc.	1	$24
Agiliti Surgical, Inc.	1	$23
Medtronic	1	$20
180 Medical, Inc.	1	$18
Otsuka America Pharmaceutical, Inc.	1	$17
SWAN Valley Medical Incorporated	3	$0

How this compares

$639,845 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$599,833

Medicare patients

974

Services billed

12,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Syracuse

Christopher PieczonkaSyracuse$31.2M
Gennady BratslavskySyracuse$2.5M
Joseph JacobSyracuse$1M
Po LamSyracuse$579K
Guarionex DecastroNew York$5.7M
Mitchell EfrosGarden City$4.2M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Jed KaminetskyMiddle Village$3.5M
Evan GoldfischerPoughkeepsie$3.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →